Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

80.63
+2.453.13%
Post-market: 81.711.08+1.33%17:24 EDT
Volume:552.01K
Turnover:44.16M
Market Cap:4.43B
PE:23.78
High:80.77
Open:78.70
Low:78.30
Close:78.18
52wk High:85.76
52wk Low:48.82
Shares:54.93M
Float Shares:54.68M
Volume Ratio:1.12
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.39
EPS(LYR):-4.4500
ROE:15.40%
ROA:5.04%
PB:3.34
PE(LYR):-18.12

Loading ...

LivaNova Director Francesco Bianchi Sells 3,500 Shares for $273,032.20

Reuters
·
2 hours ago

LivaNova Director Brooke Story Sells 2,300 Shares for $187,270.14

Reuters
·
Sep 09

LivaNova Presents at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 03

LivaNova Files Form 3 for Chief Legal Officer Anne M. Liddy

Reuters
·
Sep 03

LivaNova Director Francesco Bianchi Sells 1,650 Shares for $131,538

Reuters
·
Sep 03

LivaNova Price Target Raised to $90.00/Share from $87.00 by Piper Sandler

Dow Jones
·
Sep 03

LivaNova price target raised to $90 from $87 at Piper Sandler

TIPRANKS
·
Sep 02

LivaNova Chief Innovation Officer Ahmet Tezel Disposes of Shares Worth $435,409.36

Reuters
·
Aug 14

iRhythm Q2 Revenue Beats Estimates on Sustained Volume Demand, Lifts FY Guidance

Reuters
·
Aug 07

Pulse Biosciences Q2 Net Loss Widens, Cash Position Strengthens

Reuters
·
Aug 07

LivaNova PLC Lifts Guidance on Record Q2 Results

TIPRANKS
·
Aug 06

Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop

Reuters
·
Aug 06

LivaNova is Maintained at Buy by Needham

Dow Jones
·
Aug 06

LivaNova PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance

TradingKey
·
Aug 05

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

Reuters
·
Aug 05

GUIDANCE: (LIVN) LivaNova Expects 2026 Adjusted EPS Range $4.30 to $4.40, vs. FactSet Est of $4.25

MT Newswires Live
·
Aug 05

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

Reuters
·
Aug 05

LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement

Reuters
·
Aug 05